How are HLA-DQ2 and Darmgesundheit related?

HLA-DQ2 is a genetic marker strongly associated with celiac disease, an autoimmune condition where gluten from wheat, rye, and barley triggers inflammation of the small intestinal lining. This inflammation damages the villi, leading to malabsorption, diarrhea, bloating, and long-term nutrient deficiencies. Gut health (Darmgesundheit) is therefore directly impacted. However, HLA-DQ2 is not diagnostic: about 30–40% of the population carry the allele, but only a minority develop celiac disease. The disease requires gluten exposure and additional genetic or environmental triggers. A positive HLA-DQ2 test cannot confirm celiac disease, but a negative test effectively rules it out. For overall gut health, other factors like microbiome composition, diet, and inflammation are also critical. The evidence for the HLA-DQ2–celiac link is human-strong (numerous GWAS and clinical studies), but its predictive value for individuals is limited. Genetic testing alone should not replace medical evaluation (e.g., antibody tests and biopsy).